The Northern Ireland/Australian family with multiple endocrine neoplasia type 2A (MEN 2A) originally described in 1987 is presented with a revised and enlarged pedigree. Four members of the first generation studied have died. A seventh member of the second generation studied has developed medullary thyroid carcinoma and has progressed to surgery. None of the third generation members studied has shown any conclusive abnormality in metabolic screening tests. Each member of the third and fourth generations has had genetic counseling and (if appropriate) DNA analysis with gene probes close to the MEN 2A gene locus on chromosome 10. All members of this highly penetrant family have remained asymptomatic for their disease
BACKGROUND: Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited cancer...
The American Thyroid Association recently classified all MEN2A-associated codons into increasing ris...
AbstractBackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare cancer associated-syndrome,...
A Northern Ireland/Australian family with multiple endocrine neoplasia type 2A is described. Three m...
Linkage analysis has been performed in four pedigrees with multiple endocrine neoplasia type 2A (MEN...
A Japanese family of 87 members in five generations with multiple endocrine neoplasia type 2A (MEN 2...
Results of screening and follow-up in a family with the MEN-2A syndrome are described. Fourteen (83%...
We describe familial cases of multiple endocrine neoplasia (MEN) 2B: A 48-year-old man is the proban...
Nine chromosome 10 DNA markers (FNRB, D10S34, D10Z1, MEN203, D10S94, RBP3, D10S15, MBP [48.11], D10S...
Seven members with multiple endocrine neoplasia type 2B from a 15-member family have been followed f...
INTRODUCTION: Multiple Endocrine Neoplasia (MEN) is a rare autosomal dominant disease with frequency...
Results of follow-up studies in four large multiple endocrine neoplasia type 2A families (total of 9...
MEN-2A is characterized by medullary thyroid carcinoma (MTC) with pheochromocytoma and sometimes par...
We have performed linkage analysis on 32 families with hereditary medullary thyroid cancer (MTC) wil...
Family .screening for medullary thyroid cancer (MTC) is important for detecting members of multiple ...
BACKGROUND: Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited cancer...
The American Thyroid Association recently classified all MEN2A-associated codons into increasing ris...
AbstractBackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare cancer associated-syndrome,...
A Northern Ireland/Australian family with multiple endocrine neoplasia type 2A is described. Three m...
Linkage analysis has been performed in four pedigrees with multiple endocrine neoplasia type 2A (MEN...
A Japanese family of 87 members in five generations with multiple endocrine neoplasia type 2A (MEN 2...
Results of screening and follow-up in a family with the MEN-2A syndrome are described. Fourteen (83%...
We describe familial cases of multiple endocrine neoplasia (MEN) 2B: A 48-year-old man is the proban...
Nine chromosome 10 DNA markers (FNRB, D10S34, D10Z1, MEN203, D10S94, RBP3, D10S15, MBP [48.11], D10S...
Seven members with multiple endocrine neoplasia type 2B from a 15-member family have been followed f...
INTRODUCTION: Multiple Endocrine Neoplasia (MEN) is a rare autosomal dominant disease with frequency...
Results of follow-up studies in four large multiple endocrine neoplasia type 2A families (total of 9...
MEN-2A is characterized by medullary thyroid carcinoma (MTC) with pheochromocytoma and sometimes par...
We have performed linkage analysis on 32 families with hereditary medullary thyroid cancer (MTC) wil...
Family .screening for medullary thyroid cancer (MTC) is important for detecting members of multiple ...
BACKGROUND: Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited cancer...
The American Thyroid Association recently classified all MEN2A-associated codons into increasing ris...
AbstractBackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare cancer associated-syndrome,...